523
Views
8
CrossRef citations to date
0
Altmetric
Clinical Focus: Neurological and Psychiatric Disorders

Time-to-onset and -resolution of adverse events before/after atomoxetine discontinuation in adult patients with ADHD

, , , , , , & show all
Pages 677-685 | Received 07 Apr 2015, Accepted 12 Aug 2015, Published online: 31 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sharon B Wigal, Tim Wigal, Mary Hobart, Jessica J Madera, Ross A Baker, Eva Kohegyi, Anthony McKinney & Timothy E Wilens. (2020) Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Neuropsychiatric Disease and Treatment 16, pages 1411-1426.
Read now

Articles from other publishers (6)

Iman Idrees, Alessio Bellato, Samuele Cortese & Madeleine J. Groom. (2023) The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 144, pages 104968.
Crossref
Falk Kiefer, Sabine Hoffmann, Julia Arens, Martin Beutel, Oliver Bilke-Hentsch, Gallus Bischof, Udo Bonnet, Jan Malte Bumb, Ralf Demmel, Silke Diestelkamp, Patric Driessen, Isabel Englert, Ursula Fennen, Heribert Fleischmann, Jennis Freyer-Adam, Wilma Funke, Dieter Geyer, Euphrosyne Gouzoulis-Mayfrank, Renate Hannak-Zeltner, Barbara Hansen, Ursula Havemann-Reinecke, Derik Hermann, Eva Hoch, Werner Höhl, Susann Hößelbarth, Kristin Hupfer, Julia Jückstock, Marianne Klein, Andreas Koch, Joachim Köhler, Michael Köhnke, Anne Koopmann, Oliver Kreh, Monika Krönes, Dietmar Kramer, Georg Kremer, Timo Krüger, Nikolaus Lange, Bodo Lieb, Johannes Lindenmeyer, Mathias Luderer, Karl Mann, Peter Missel, Sebastian Mueller, Michael Müller-Mohnssen, Corinna Nels-Lindemann, Tim Neumann, Thomas Polak, Ulrich W. Preuss, Olaf Reis, Gerhard Reymann, Monika Ridinger, Hans-Jürgen Rumpf, Peter-Michael Sack, Ingo Schäfer, Martin Schäfer, Norbert Scherbaum, Ariane Schulte, Welf Schroeder, Manfred Singer, Michael Soyka, Rainer Thomasius, Clemens Veltrup, Monika Vogelgesang, Irmgard Vogt, Marc Walter, Tillmann Weber, Georg Weil, Bernd Wessel, Tina Wessels, Klaudia Winkler, Nadja Wirth, Arnold Wieczorek, Norbert Wodarz & Dirk Wolter. 2022. S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen. S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen 51 356 .
Mathias Luderer, Josep Antoni Ramos Quiroga, Stephen V. Faraone, Yanli Zhang-James & Andreas Reif. (2021) Alcohol use disorders and ADHD. Neuroscience & Biobehavioral Reviews 128, pages 648-660.
Crossref
Lorenzo Soldati, Francesco Bianchi-Demicheli, Pauline Schockaert, John Köhl, Mylène Bolmont, Roland Hasler & Nader Perroud. (2020) Sexual Function, Sexual Dysfunctions, and ADHD: A Systematic Literature Review. The Journal of Sexual Medicine 17:9, pages 1653-1664.
Crossref
Jose Martinez-Raga, Amparo Ferreros, Carlos Knecht, Raquel de Alvaro & Eloisa Carabal. (2016) Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes. Therapeutic Advances in Drug Safety 8:3, pages 87-99.
Crossref
Matthew R. Zahner & Nicholas T. Bello. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 1 10 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.